STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

CUSIP: 34385P108

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
384,731,503
Total 13F shares
281,191,207
Share change
+9,481,224
Total reported value
$542,598,457
Put/Call ratio
125%
Price per share
$1.93
Number of holders
141
Value change
+$19,046,404
Number of buys
56
Number of sells
66

Quarterly Holders Quick Answers

What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Casdin Capital, LLC
13F
Company
17%
63,959,677
$113,208,628 30 Jun 2024
13F
VIKING GLOBAL INVESTORS LP
13F 3/4/5
Company · 10%+ Owner
15%
58,651,170
$103,812,571 30 Jun 2024
BlackRock Finance, Inc.
13F
Company
5.7%
21,753,007
$38,502,822 30 Jun 2024
13F
Caligan Partners LP
3/4/5
10%+ Owner
mixed-class rows
16,265,374
mixed-class rows
$34,539,714 29 Jun 2023
VANGUARD GROUP INC
13F
Company
4.2%
16,003,158
$28,325,590 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
3.4%
12,934,541
$22,894,137 30 Jun 2024
13F
ARK Investment Management LLC
13F
Company
3.3%
12,679,391
$22,442,522 30 Jun 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
2.8%
10,642,271
$18,836,820 30 Jun 2024
13F
Amova Asset Management Americas, Inc.
13F
Company
2.8%
10,642,271
$18,730,397 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
6,794,869
$12,029,291 30 Jun 2024
13F
Tikvah Management LLC
13F
Company
1.7%
6,551,058
$11,595,373 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.6%
6,221,993
$11,012,928 30 Jun 2024
13F
STATE STREET CORP
13F
Company
1.1%
4,337,152
$7,676,759 30 Jun 2024
13F
Neuberger Berman Group LLC
13F
Company
1.1%
4,137,246
$7,322,926 30 Jun 2024
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.78%
3,008,643
$5,325,298 30 Jun 2024
13F
BARCLAYS PLC
13F
Company
0.74%
2,851,165
$5,046,562 30 Jun 2024
13F
Nan Fung Group Holdings Ltd
13F
Company
0.49%
1,883,179
$3,333,227 30 Jun 2024
13F
Slate Path Capital LP
13F
Company
0.42%
1,615,000
$2,858,550 30 Jun 2024
13F
Jeffrey G. Black
3/4/5
SVP & Chief Financial Officer
mixed-class rows
966,346
mixed-class rows
$2,532,070 20 Aug 2024
Qube Research & Technologies Ltd
13F
Company
0.32%
1,229,132
$2,175,564 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.26%
1,004,558
$1,778,068 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.26%
1,002,377
$1,774,207 30 Jun 2024
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.26%
998,162
$1,766,747 30 Jun 2024
13F
NEEDHAM INVESTMENT MANAGEMENT LLC
13F
Company
0.26%
984,435
$1,742,450 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.25%
980,983
$1,736,339 30 Jun 2024
13F
Jennifer C. Price
13F
Individual
0.25%
980,100
$1,734,777 30 Jun 2024
13F
Invenomic Capital Management LP
13F
Company
0.25%
950,114
$1,681,702 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.24%
905,346
$1,602,462 30 Jun 2024
13F
GAGNON SECURITIES LLC
13F
Company
0.23%
898,509
$1,590,361 30 Jun 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.22%
847,355
$1,499,818 30 Jun 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.2%
783,152
$1,386,179 30 Jun 2024
13F
Pacific Capital Partners Ltd
13F
Company
0.19%
750,000
$1,327,500 30 Jun 2024
13F
Magnetar Financial LLC
13F
Company
0.18%
692,998
$1,226,606 30 Jun 2024
13F
Gagnon Advisors, LLC
13F
Company
0.17%
672,294
$1,189,960 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.17%
640,983
$1,134,539 30 Jun 2024
13F
Casdin Amplify Fund, LP
3/4/5
Director
class O/S missing
545,000
$1,117,250 18 Jun 2024
Stephen Christopher Linthwaite
3/4/5
President & CEO
mixed-class rows
390,252
mixed-class rows
$1,004,213 22 Feb 2022
Walleye Capital LLC
13F
Company
0.15%
561,521
$993,892 30 Jun 2024
13F
PARADIGM CAPITAL MANAGEMENT INC/NY
13F
Company
0.14%
550,000
$973,500 30 Jun 2024
13F
Swiss National Bank
13F
Company
0.13%
488,860
$865,282 30 Jun 2024
13F
Vikram Jog
3/4/5
Chief Financial Officer
mixed-class rows
297,859
mixed-class rows
$762,479 21 Feb 2023
Intellectus Partners, LLC
13F
Company
0.11%
419,702
$742,873 30 Jun 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.11%
417,917
$739,713 30 Jun 2024
13F
Redmile Group, LLC
13F
Company
0.11%
411,631
$728,587 30 Jun 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.11%
407,467
$721,209 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.1%
403,529
$714,246 30 Jun 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.1%
382,488
$677,004 30 Jun 2024
13F
Jeremy Steven Davis
3/4/5
SVP Chief Commercial Officer
mixed-class rows
243,824
mixed-class rows
$667,438 21 Feb 2023
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.09%
362,385
$641,421 30 Jun 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.08%
315,690
$558,771 30 Jun 2024
13F

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q3 2024

As of 30 Sep 2024, STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by 141 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 281,191,207 shares. The largest 10 holders included Casdin Capital, LLC, VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., ARK Investment Management LLC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 141 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
142
Q3 2024 holders
141
Holder diff
-1
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .